Inositec - Ownership and Business Overview

Life ScienceCompany

Inositec Ownership

Who owns Inositec?

Inositec is owned by Vifor Pharma AG. It was acquired on November 22, 2021.

Inositec Business Overview

Where is Inositec headquartered?

Inositec is headquartered in Zurich, Switzerland.

What sector is Inositec in?

Inositec is a life science company.

When was Inositec founded?

Inositec was founded in 2015.

Life Science M&A Summary in 2021

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2021. The largest life science acquisition in 2021 was Pharmaceutical Product Development - which was acquired by Thermo Fisher Scientific for $17.4B.

Join Mergr to view all 392 acquisitions of life science companies in 2021, including 46 acquisitions by private equity firms, and 346 by strategics.

Inositec

Inositec AG

Technoparkstrasse 1,
Zurich, 8005
Switzerland,
+41 44 271 07 55
www.inositec.com

Inositec is developing first-in-class treatments for soft tissue calcification disorders based on its proprietary Inositune platform of inositol phosphate (IP6) analogs. The company’s lead programs address vascular and renal calcification disorders, including orphan indications. Inositec’s novel asset INS-3001, is a once-daily subcutaneous treatment for patients with vascular calcification disorders PAD and AVS, which are both major contributors to cardiovascular morbidity and mortality in affected patient populations. With INS-3001 daily subcutaneous dosing, patients with earlier stages of vascular calcification can be optimally treated, while end-stage kidney disease patients will benefit from the three times per week dosing regimen of SNF472. Inositec was formed in 2015 and is based in Zurich, Switzerland.


Company Summary

SECTOR

Life Science

Established

2015

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Inositec

Life Science Companies , Switzerland Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for Switzerland Companies

Largest Switzerland Companies , Acquisitive Switzerland Companies , Recently Acquired Switzerland Companies , Recently Sold Switzerland Companies , Private Switzerland Companies , Public Switzerland Companies , Acquired Switzerland Companies , PE Backed Switzerland Companies
Mergr

Product

Company

Legal